Copyright Reports & Markets. All rights reserved.

Global and Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Gastro Esophageal Reflux Disease (GERD) Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Type
    • 1.4.2 H2 Receptor Antagonist
    • 1.4.3 Proton Pump Inhibitor (PPi)
    • 1.4.4 Antacids
  • 1.5 Market by Application
    • 1.5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Medical Center
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2015-2026
    • 2.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2015-2026
  • 2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Gastro Esophageal Reflux Disease (GERD) Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Region (2021-2026)

3 Global Gastro Esophageal Reflux Disease (GERD) Drug Competitor Landscape by Players

  • 3.1 Global Top Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers
    • 3.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers by Revenue
    • 3.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Gastro Esophageal Reflux Disease (GERD) Drug Revenue in 2019
    • 3.2.5 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturers
  • 3.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2015-2020)
    • 4.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2015-2020)
    • 4.1.3 Gastro Esophageal Reflux Disease (GERD) Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Gastro Esophageal Reflux Disease (GERD) Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Application (2015-2020)
    • 5.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2015-2020)
    • 5.1.3 Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2015-2020)
  • 5.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application

  • 6.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
    • 6.1.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales YoY Growth 2015-2026
    • 6.1.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue YoY Growth 2015-2026
    • 6.1.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Share in Global Market 2015-2026
  • 6.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Players (International and Local Players)
    • 6.2.1 Japan Top Gastro Esophageal Reflux Disease (GERD) Drug Players by Sales (2015-2020)
    • 6.2.2 Japan Top Gastro Esophageal Reflux Disease (GERD) Drug Players by Revenue (2015-2020)
  • 6.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2015-2020)
  • 6.4 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Type (2021-2026)
  • 6.5 Japan Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2015-2020)
  • 6.6 Japan Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 Japan Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 Japan Gastro Esophageal Reflux Disease (GERD) Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
    • 7.2.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2015-2020)
    • 7.2.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
    • 8.2.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
    • 8.2.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
    • 10.2.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
    • 11.2.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Pfizer
    • 12.1.1 Pfizer Corporation Information
    • 12.1.2 Pfizer Description and Business Overview
    • 12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.1.5 Pfizer Recent Development
  • 12.2 Novartis AG
    • 12.2.1 Novartis AG Corporation Information
    • 12.2.2 Novartis AG Description and Business Overview
    • 12.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.2.5 Novartis AG Recent Development
  • 12.3 GlaxoSmithKline
    • 12.3.1 GlaxoSmithKline Corporation Information
    • 12.3.2 GlaxoSmithKline Description and Business Overview
    • 12.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.3.5 GlaxoSmithKline Recent Development
  • 12.4 Merck
    • 12.4.1 Merck Corporation Information
    • 12.4.2 Merck Description and Business Overview
    • 12.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.4.5 Merck Recent Development
  • 12.5 Medtronic
    • 12.5.1 Medtronic Corporation Information
    • 12.5.2 Medtronic Description and Business Overview
    • 12.5.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.5.5 Medtronic Recent Development
  • 12.11 Pfizer
    • 12.11.1 Pfizer Corporation Information
    • 12.11.2 Pfizer Description and Business Overview
    • 12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
    • 12.11.5 Pfizer Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Gastro Esophageal Reflux Disease (GERD) Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Gastro Esophageal Reflux Disease (GERD) Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Gastro Esophageal Reflux Disease (GERD) Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Gastro Esophageal Reflux Disease (GERD) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into
    H2 Receptor Antagonist
    Proton Pump Inhibitor (PPi)
    Antacids

    Segment by Application, the Gastro Esophageal Reflux Disease (GERD) Drug market is segmented into
    Hospital
    Clinic
    Medical Center
    Others

    Regional and Country-level Analysis
    The Gastro Esophageal Reflux Disease (GERD) Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Gastro Esophageal Reflux Disease (GERD) Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Gastro Esophageal Reflux Disease (GERD) Drug Market Share Analysis
    Gastro Esophageal Reflux Disease (GERD) Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastro Esophageal Reflux Disease (GERD) Drug business, the date to enter into the Gastro Esophageal Reflux Disease (GERD) Drug market, Gastro Esophageal Reflux Disease (GERD) Drug product introduction, recent developments, etc.
    The major vendors covered:
    Pfizer
    Novartis AG
    GlaxoSmithKline
    Merck
    Medtronic
    ...

    Buy now